




POLICY AND PRACTICE UPDATES    
 
Private Hospitals: the Wenzhou Experience  
Source: Economy Observer 2010-12-18 
http://www.chinadaily.com.cn/hqss/jiankang/2010-12-20/content_1420998.html  
 
Private hospitals are embracing the best opportunity of development in history, according to Guan 
Weili, president of the Wenzhou Private Medical Association and the Chief Executive Officer of 
Kangning Hospital. Guan predicts that if this round of medical reform can be promptly and properly 
executed, private hospitals in Wenzhou and even in China could soon outperform their public 
counterparts. Previously, private capitals were set apart from the medical industry. In Wenzhou, 
private hospitals are usually small, sparsely distributed, low end focused, and lacking government 
support. Recent government policies promised to provide more financial support to private 
hospitals and more tax benefits for private investors in the medical sector.  
 
The experience in Taiwan has demonstrated that opening the hospital market to private capital 
can improve the welfare of the public, and owners of private hospitals are preparing for the new 
opportunities. 
 
Public Hospital Reforms: Will Conglomeration Work?  
Source: 21st Century Economic Reporter 2010-12-21 
http://www.21cbh.com/HTML/2010-12-21/xOMDAwMDIxMTcxOQ.html 
 
At the end of 2009, Zhenjiang became the pioneer city to kick off China’s public hospital reform, 
followed by several east coast cities. They attempted to consolidate the resources of several 
member hospitals to form a conglomerate, hoping to achieve higher efficiency. The consolidation 
allowed public hospitals to divert their patients to primary care facilities for basic medical care, 
which led to a 15% deduction in medical cost for patients when they seek services in community 
hospitals. 
 
However, that reform is now facing a bottleneck. Challenges arise from the complicated 
interactions between the government, the Bureau of Health and the boards of the member 
hospitals. In addition, the assets of the member hospitals could not be easily determined; impeding 
shareholding system reform. Profit allocation is also an issue in need of resolution. 
 
For public hospital conglomeration to be successful, we need to achieve the following three goals: 
1) to distinguish the supervising body from the hospital daily operation system, 2) to reach optimal 
medical assets allocation, and 3) to facilitate cooperation between various medical institutions. The 
first goal aims to improve the conglomerate’s external system, while the second and third goals aim 
to build better internal management systems.  
 
Health Care Planning Lags behind Industrial Growth  
Source: 21st Century Economic Report 2011-01-01 
http://www.21cbh.com/HTML/2011-1-1/1NMDAwMDIxNDA1Nw.html 
 
Pharmaceutical industry has been regarded as one of the most promising emerging industries in 
China. With improved living standards and accelerated population aging, biotechnology and 
healthcare industries have become increasingly critical to China. After launching the 12th Five-Year 
Plan in last November, various official documents have been issued to accelerate the structural 
adjustment of pharmaceutical industry.  
 
During a recent interview,Yu Mingde, the Associate Director of Biologist and Medical Committee of 
the National Development and Reform Commission (NDRC), stated the achievements in the past 5 
14 
 
years, also the challenges facing the country today. Specifically, he commented on the important 
roles of the healthcare reforms and the entry of multi-national pharmaceutical firms into China. He 
also expressed his concern that medical industrial growth will always outstrip health care planning, 
so it is imperative that NDRC should constantly adjust their plan and provide better guidance to the 
development of the nation’s health care. 
 
The Launching of Chongqing Medicine Exchange: A New Approach to Medicine Procurement 
Reform 
Source: 21st Century Economic Report 2011-01-05 
http://www.21cbh.com/HTML/2011-1-5/zMMDAwMDIxNDMzMw.html 
 
Chongqing Medicine Exchange, launched on Sep 29 2010, is the first of its kind in China. “As a 
government-led third-party platform, Chongqing Medicine Exchange establishes the first drug 
transaction system that combines information, trading, clearing, and settlement services. A 
proactive trial in reducing drug prices and curbing corruption in health care will also be carried out 
within this framework”, said Huang Qifan, the mayor of Chongqing. 
 
The Exchange will use screen trading, and provide services for manufacturers, businesses, and 
healthcare institutions. Price index based on bid prices will be released, complete with product 
information provided by manufacturers, so that distributors and hospitals can directly negotiate 
with suppliers. A higher level of information transparency and fewer intermediaries will help build an 
efficient medical price searching mechanism. In addition, the Exchange is also responsible for 
transaction settlement and product delivery, providing an important link in stabilizing prices of non-
essential medicines. 
 
The establishment of the Exchange marks a milestone in the local pharmaceutical market reform, 
and serves as a model for the central government to reform the national medicine delivery system. 
“It is a major reform in the pharmaceutical market. It urges governments to invest more in public 
health and promote reforms of public hospitals”, said Liu Gaoqing, Chairman of the Exchange. 
 
Ten Years of Healthcare Reform in Shanghai 
Source: 21st Century Economic Reporter 2011-01-22 
http://www.21cbh.com/HTML/2011-1-24/5OMDAwMDIxNzg5OA.html 
 
The year 2011 marks the tenth anniversary of the healthcare reforms in Shanghai, which pioneered 
in separating the hospital management from government supervision. To meet the challenges of 
defining property rights, Shanghai introduced a new organization named Shen Kang to supervise 
the hospital assets invested by public finance and private sources.  
 
One distinguished achievements of Shen Kang is the implementation of full cost accounting system 
to analyze revenue and cost, helping hospitals to optimize their asset allocation. In addition, Shen 
Kang helps identifying reasons for financial losses, and providing credentials for financial subsidies. 
Shen Kang is also active in establishing cooperation with major foreign medical groups and raising 
private capital investments. Its goal is to integrate public hospital technology and private sector 
funds with foreign company management expertise, to produce a better health care system.  
 
Insufficient Government Funding Leads to Dilemma between Public Hospital Reforms and Essential 
Medicine Policy  
Source: 21st Century Economic Report 2011-02-16 
http://www.21cbh.com/HTML/2011-2-17/5OMDAwMDIyMDc5OQ.html 
 
The first plenary session of the National Healthcare System Reform Conference held by the state 





system, reinforcing the public hospital reforms, and coordinating the development of five key areas 
of the reform.  
 
Based on the timetable of public hospital reform, the essential medicine system will be 
implemented at the primary care level by the end of 2011, with the public hospitals reform entering 
a key stage. However, due to the limited financial support from the central government, carrying 
out the two tasks simultaneously might be difficult.  
 
Based on recent research, the implementation of the two reform campaigns at the primary care 
level has not been successful. Hospital administrators constantly complain about the loss of revenue 
from the essential medicine reform and the lack of financial resources for the public hospital 
management reforms. Under the current policies, it is also not clear how best to support and 
encourage privately owned hospitals to enter the medical care deliverer market.  
 
 
 
